As of 2026-03-28, the EV/EBITDA ratio of Adicet Bio Inc (ACET) is -0.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Adicet's latest enterprise value is 24.18 mil USD. Adicet's TTM EBITDA according to its financial statements is -128.05 mil USD. Dividing these 2 quantities gives us the above Adicet EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2026-03-23 | -0.20 |
| 2026-03-20 | -0.22 |
| 2026-03-19 | -0.23 |
| 2026-03-18 | -0.22 |
| 2026-03-17 | -0.24 |
| 2026-03-16 | -0.24 |
| 2026-03-13 | -0.24 |
| 2026-03-12 | -0.23 |
| 2026-03-11 | -0.26 |
| 2026-03-10 | -0.27 |
| 2026-03-09 | -0.27 |
| 2026-03-06 | -0.25 |
| 2026-03-05 | -0.26 |
| 2026-03-04 | -0.27 |
| 2026-03-03 | -0.23 |
| 2026-03-02 | -0.25 |
| 2026-02-27 | -0.25 |
| 2026-02-26 | -0.25 |
| 2026-02-25 | -0.26 |
| 2026-02-24 | -0.26 |
| 2026-02-23 | -0.22 |
| 2026-02-20 | -0.24 |
| 2026-02-19 | -0.26 |
| 2026-02-18 | -0.23 |
| 2026-02-17 | -0.23 |
| 2026-02-13 | -0.22 |
| 2026-02-12 | -0.21 |
| 2026-02-11 | -0.21 |
| 2026-02-10 | -0.24 |
| 2026-02-09 | -0.25 |
| 2026-02-06 | -0.23 |
| 2026-02-05 | -0.19 |
| 2026-02-04 | -0.26 |
| 2026-02-03 | -0.28 |
| 2026-02-02 | -0.30 |
| 2026-01-30 | -0.30 |
| 2026-01-29 | -0.34 |
| 2026-01-28 | -0.34 |
| 2026-01-27 | -0.34 |
| 2026-01-26 | -0.36 |
| 2026-01-23 | -0.34 |
| 2026-01-22 | -0.33 |
| 2026-01-21 | -0.31 |
| 2026-01-20 | -0.30 |
| 2026-01-16 | -0.32 |
| 2026-01-15 | -0.30 |
| 2026-01-14 | -0.33 |
| 2026-01-13 | -0.33 |
| 2026-01-12 | -0.29 |
| 2026-01-09 | -0.31 |